— Know what they know.
Not Investment Advice
Also trades as: IPCALAB.BO (BSE) · $vol 1M

IPCALAB.NS NSE

Ipca Laboratories Limited
1W: -2.7% 1M: -2.2% 3M: +9.2% YTD: +36.2% 1Y: +42.4% 3Y: +121.2% 5Y: +54.9%
₹1,961.90 ($20.38)
+18.70 (+0.96%)
 
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 49 · ₹493.5B mcap · 139M float · 0.256% daily turnover

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 05, 2026
DCF
4
ROE
1
ROA
1
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IPCALAB.NS receives an overall rating of C. Strongest factors: DCF (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 C- C
2026-08-17 B+ C-
2026-08-10 A- B+
2026-07-01 B+ A-
2026-06-01 C B+
2026-03-23 C- C
2026-02-18 B+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 71 Grade A+
Profitability
61
Balance Sheet
88
Earnings Quality
69
Growth
63
Value
51
Momentum
90
Safety
100
Cash Flow
66
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. IPCALAB.NS scores highest in Safety (100/100) and lowest in Value (51/100). An overall grade of A+ places IPCALAB.NS among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
10.17
Safe Zone
Piotroski F-Score
9/9
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Beneish M-Score
-2.68
Unlikely Manipulator
Ohlson O-Score
-12.20
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 94.7/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.49x
Accruals: -4.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IPCALAB.NS scores 10.17, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IPCALAB.NS scores 9/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. IPCALAB.NS's score of -2.68 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IPCALAB.NS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IPCALAB.NS receives an estimated rating of AA+ (score: 94.7/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). IPCALAB.NS's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
38.27x
PEG
0.56x
P/S
4.95x
P/B
6.22x
P/FCF
58.88x
P/OCF
23.85x
EV/EBITDA
19.88x
EV/Revenue
4.17x
EV/EBIT
24.94x
EV/FCF
58.31x
Earnings Yield
2.81%
FCF Yield
1.70%
Shareholder Yield
0.29%
Graham Number
$567.24
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 38.3x earnings, IPCALAB.NS commands a growth premium. Graham's intrinsic value formula yields $567.24 per share, 243% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.728
NI / EBT
×
Interest Burden
0.972
EBT / EBIT
×
EBIT Margin
0.167
EBIT / Rev
×
Asset Turnover
0.800
Rev / Assets
×
Equity Multiplier
1.607
Assets / Equity
=
ROE
15.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IPCALAB.NS's ROE of 15.2% is driven by Asset Turnover (0.800), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$1731.94
Price/Value
0.92x
Margin of Safety
7.55%
Premium
-7.55%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with IPCALAB.NS's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. IPCALAB.NS actually compounded EPS at 34.2% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. IPCALAB.NS trades at a -8% premium to its adjusted intrinsic value of $1731.94, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 38.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1943.20
Median 1Y
$2271.94
5th Pctile
$1390.73
95th Pctile
$3718.34
Ann. Volatility
30.5%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
ROE 24.0% 20.4% 19.0% 17.3% 14.1% 11.1% 9.5% 8.3% 8.7% 8.3% 9.5% 9.0% 9.5% 10.3% 11.4% 11.1% 11.7% 11.8% 12.9% 15.2% 15.20%
ROA 17.7% 15.5% 14.4% 12.9% 10.5% 8.3% 7.1% 5.8% 6.0% 5.1% 5.9% 5.5% 5.8% 5.8% 6.4% 6.5% 6.8% 7.0% 7.7% 9.5% 9.46%
ROIC 43.7% 40.1% 39.5% 37.0% 34.7% 31.3% 30.3% 28.8% 29.1% 22.4% 25.8% 26.8% 29.5% 32.2% 34.1% 35.4% 36.8% 29.7% 24.3% 22.9% 22.94%
ROCE 23.2% 20.5% 19.4% 17.2% 14.7% 12.2% 10.7% 10.3% 10.8% 8.8% 9.8% 10.7% 11.3% 12.2% 13.6% 13.8% 14.1% 14.3% 15.3% 16.0% 16.03%
Gross Margin 65.1% 64.8% 65.1% 52.0% 63.5% 64.1% 63.7% 46.7% 67.5% 66.7% 66.0% 52.9% 69.2% 67.8% 70.2% 55.0% 70.0% 69.4% 45.7% 71.0% 71.04%
Operating Margin 46.0% 45.6% 45.3% 16.9% 43.2% 44.2% 43.1% 13.8% 45.0% 45.7% 43.7% 20.7% 45.9% 46.1% 48.6% 23.4% 46.5% 17.3% 18.4% 15.8% 15.77%
Net Margin 19.6% 16.2% 13.8% 10.1% 9.0% 9.0% 7.0% 5.0% 10.3% 7.1% 8.8% 2.9% 9.2% 9.7% 11.1% 3.0% 10.1% 11.1% 13.6% 12.5% 12.52%
EBITDA Margin 26.1% 23.6% 20.8% 15.1% 16.5% 16.2% 13.1% 13.9% 18.8% 15.3% 14.2% 15.4% 18.0% 18.7% 19.9% 17.3% 17.7% 20.1% 23.9% 22.2% 22.15%
FCF Margin 9.1% 10.9% 12.9% 11.0% 9.4% 8.4% 7.5% 7.9% 8.6% 8.8% 9.1% 8.5% 7.9% 7.0% 6.1% 5.9% 5.6% 7.5% 7.3% 7.2% 7.15%
OCF Margin 15.2% 17.0% 19.3% 17.7% 16.6% 14.0% 11.4% 9.8% 8.6% 8.8% 9.1% 9.8% 10.4% 10.6% 10.8% 11.5% 12.1% 17.7% 18.3% 17.7% 17.66%
ROE 3Y Avg snapshot only 11.14%
ROE 5Y Avg snapshot only 11.52%
ROA 3Y Avg snapshot only 6.81%
ROIC 3Y Avg snapshot only 12.81%
ROIC Economic snapshot only 20.28%
Cash ROA snapshot only 13.77%
Cash ROIC snapshot only 22.19%
CROIC snapshot only 8.99%
NOPAT Margin snapshot only 18.25%
Pretax Margin snapshot only 16.25%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 12.42%
SBC / Revenue snapshot only 0.01%
Valuation
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
P/E Ratio 25.41 30.76 29.73 30.28 31.26 37.41 40.50 43.30 38.13 47.91 49.84 57.09 49.47 57.30 58.88 51.64 45.23 40.84 39.56 35.59 38.267
P/S Ratio 4.66 5.37 4.81 4.59 3.85 3.89 3.53 3.27 3.00 3.53 3.91 4.05 3.47 4.44 4.92 4.26 3.85 3.63 3.79 4.21 4.950
P/B Ratio 5.41 5.75 5.17 4.87 4.10 3.98 3.68 3.49 3.21 3.84 4.57 4.93 4.51 5.65 6.41 5.48 5.07 4.57 4.85 5.04 6.216
P/FCF 51.38 49.40 37.34 41.78 40.74 46.12 47.34 41.31 34.79 39.88 42.79 47.96 44.14 63.25 80.53 72.58 68.20 48.40 51.93 58.88 58.877
P/OCF 30.68 31.51 24.96 25.95 23.15 27.75 30.88 33.25 34.79 39.88 42.79 41.42 33.49 41.75 45.47 37.09 31.73 20.54 20.73 23.85 23.849
EV/EBITDA 18.68 22.08 20.81 20.71 19.64 22.12 22.53 21.09 18.54 24.08 26.22 26.18 22.51 26.82 27.39 23.16 21.02 19.28 19.10 19.88 19.884
EV/Revenue 4.57 5.25 4.69 4.50 3.76 3.79 3.44 3.15 2.88 3.69 4.06 4.13 3.55 4.47 4.96 4.29 3.87 3.63 3.79 4.17 4.170
EV/EBIT 21.91 25.99 24.71 24.75 24.25 28.22 29.81 28.02 24.55 32.07 34.30 34.18 29.51 34.80 35.16 29.56 26.88 24.43 24.18 24.94 24.944
EV/FCF 50.39 48.32 36.43 40.92 39.74 44.99 46.08 39.90 33.49 41.66 44.39 48.87 45.06 63.75 81.09 73.06 68.69 48.40 51.92 58.31 58.312
Earnings Yield 3.9% 3.3% 3.4% 3.3% 3.2% 2.7% 2.5% 2.3% 2.6% 2.1% 2.0% 1.8% 2.0% 1.7% 1.7% 1.9% 2.2% 2.4% 2.5% 2.8% 2.81%
FCF Yield 1.9% 2.0% 2.7% 2.4% 2.5% 2.2% 2.1% 2.4% 2.9% 2.5% 2.3% 2.1% 2.3% 1.6% 1.2% 1.4% 1.5% 2.1% 1.9% 1.7% 1.70%
PEG Ratio snapshot only 0.561
Price/Tangible Book snapshot only 5.163
EV/OCF snapshot only 23.620
EV/Gross Profit snapshot only 6.506
Acquirers Multiple snapshot only 17.253
Shareholder Yield snapshot only 0.29%
Graham Number snapshot only $567.24
Leverage & Solvency
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Current Ratio 2.96 3.07 3.07 3.04 3.04 3.29 3.29 2.87 2.87 2.13 2.13 2.35 2.35 2.37 2.37 2.50 2.50 2.46 2.46 2.76 2.763
Quick Ratio 1.59 1.87 1.87 1.77 1.77 1.97 1.97 1.91 1.91 1.22 1.22 1.30 1.30 1.32 1.32 1.43 1.43 1.47 1.47 1.58 1.579
Debt/Equity 0.06 0.06 0.06 0.15 0.15 0.13 0.13 0.25 0.25 0.32 0.32 0.23 0.23 0.18 0.18 0.20 0.20 0.17 0.17 0.10 0.100
Net Debt/Equity -0.10 -0.13 -0.13 -0.10 -0.10 -0.10 -0.10 -0.12 -0.12 0.17 0.17 0.09 0.09 0.04 0.04 0.04 0.04 -0.00 -0.00 -0.05 -0.048
Debt/Assets 0.04 0.04 0.04 0.11 0.11 0.09 0.09 0.17 0.17 0.17 0.17 0.13 0.13 0.11 0.11 0.12 0.12 0.10 0.10 0.07 0.065
Debt/EBITDA 0.20 0.23 0.24 0.64 0.72 0.72 0.80 1.58 1.52 1.94 1.79 1.18 1.11 0.84 0.76 0.82 0.81 0.73 0.68 0.40 0.400
Net Debt/EBITDA -0.37 -0.49 -0.52 -0.44 -0.49 -0.56 -0.61 -0.75 -0.72 1.03 0.95 0.49 0.46 0.21 0.19 0.15 0.15 -0.00 -0.00 -0.19 -0.192
Interest Coverage 140.14 165.72 178.75 137.72 70.72 37.71 22.79 23.30 13.44 8.59 7.60 6.74 7.54 10.03 13.26 15.27 16.62 18.18 19.27 21.24 21.237
Equity Multiplier 1.29 1.30 1.30 1.39 1.39 1.37 1.37 1.48 1.48 1.85 1.85 1.75 1.75 1.70 1.70 1.69 1.69 1.65 1.65 1.53 1.534
Cash Ratio snapshot only 0.519
Debt Service Coverage snapshot only 26.641
Cash to Debt snapshot only 1.481
FCF to Debt snapshot only 0.853
Defensive Interval snapshot only 309.1 days
Efficiency & Turnover
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Asset Turnover 0.96 0.89 0.89 0.85 0.85 0.80 0.82 0.77 0.77 0.69 0.75 0.78 0.83 0.75 0.77 0.78 0.80 0.79 0.80 0.80 0.800
Inventory Turnover 1.38 1.44 1.42 1.28 1.30 1.35 1.39 1.40 1.37 1.20 1.26 1.35 1.41 1.23 1.22 1.23 1.24 1.25 1.50 1.31 1.309
Receivables Turnover 6.37 5.66 5.68 6.73 6.75 5.43 5.54 6.53 6.53 4.67 5.02 5.73 6.10 4.78 4.88 5.01 5.13 4.81 4.89 4.96 4.962
Payables Turnover 3.15 3.39 3.36 3.61 3.67 3.72 3.83 4.66 4.54 3.74 3.93 4.38 4.57 3.59 3.56 3.80 3.86 3.65 4.38 3.88 3.877
DSO 57 65 64 54 54 67 66 56 56 78 73 64 60 76 75 73 71 76 75 74 73.6 days
DIO 265 254 256 285 281 271 263 261 267 304 289 270 258 297 299 298 293 291 243 279 278.9 days
DPO 116 108 109 101 100 98 95 78 80 98 93 83 80 102 103 96 95 100 83 94 94.1 days
Cash Conversion Cycle 206 211 212 239 236 240 234 238 243 285 269 250 238 272 272 275 270 267 234 258 258.3 days
Fixed Asset Turnover snapshot only 1.854
Operating Cycle snapshot only 352.4 days
Cash Velocity snapshot only 8.052
Capital Intensity snapshot only 1.282
Growth (YoY)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 6.8% 8.7% 5.1% 7.6% 7.3% 4.8% 6.5% 7.2% 6.8% 13.1% 19.4% 23.4% 31.4% 27.7% 21.4% 16.0% 11.5% 9.7% 8.9% 7.9% 7.89%
Net Income 8.4% -1.3% -14.0% -22.4% -28.0% -37.6% -42.6% -46.7% -31.8% -19.9% 7.5% 16.1% 17.4% 34.3% 29.3% 34.8% 35.0% 25.8% 24.7% 54.7% 54.69%
EPS 8.2% -1.4% -14.7% -22.4% -28.0% -37.6% -42.6% -46.6% -31.8% -19.8% 7.5% 16.0% 17.4% 34.3% 29.3% 34.5% 34.9% 25.8% 24.7% 54.9% 54.90%
FCF 80.8% 1.4% 1.8% 69.9% 11.7% -18.7% -38.3% -22.9% -2.6% 18.7% 46.3% 31.9% 20.1% 1.3% -18.9% -19.4% -20.1% 17.1% 30.0% 31.4% 31.43%
EBITDA 1.4% -5.1% -15.4% -16.3% -16.2% -24.4% -27.9% -26.2% -13.1% 1.0% 21.1% 30.1% 33.1% 39.2% 41.9% 36.2% 30.4% 23.7% 19.3% 22.2% 22.20%
Op. Income 1.4% 0.4% -3.6% -2.7% 1.2% -0.4% 0.4% -1.1% 1.9% 11.6% 20.9% 30.8% 39.8% 33.6% 29.5% 23.7% 17.7% -6.9% -30.3% -36.4% -36.41%
OCF Growth snapshot only 65.79%
Asset Growth snapshot only 5.18%
Equity Growth snapshot only 16.05%
Debt Growth snapshot only -40.65%
Shares Change snapshot only -0.14%
Dividend Growth snapshot only 84.03%
Growth (CAGR)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 3Y 84.0% 44.0% 25.0% 15.6% 13.7% 11.6% 10.6% 10.3% 7.0% 8.8% 10.1% 12.5% 14.6% 14.8% 15.6% 15.3% 16.1% 16.6% 16.4% 15.6% 15.58%
Revenue 5Y — — — — — — — — 48.2% 28.8% 20.0% 15.3% 15.6% 15.0% 14.4% 14.0% 12.4% 12.5% 12.1% 12.2% 12.22%
EPS 3Y 1.4% 73.7% 38.1% 25.5% 12.4% 1.7% -5.4% -7.0% -19.0% -21.0% -19.3% -21.7% -16.8% -12.4% -7.3% -5.9% 2.6% 10.7% 20.1% 34.2% 34.23%
EPS 5Y — — — — — — — — 48.1% 21.3% 10.2% 4.1% 2.6% 2.5% 3.3% 4.6% -3.4% -3.6% -3.2% 0.0% 0.04%
Net Income 3Y 1.4% 73.9% 38.3% 25.7% 12.5% 1.9% -5.3% -8.1% -19.0% -21.0% -19.1% -21.7% -16.8% -12.4% -7.3% -5.9% 2.6% 10.6% 20.1% 34.3% 34.28%
Net Income 5Y — — — — — — — — 48.3% 21.3% 10.3% 4.2% 2.7% 2.6% 3.3% 4.0% -3.3% -3.6% -3.1% 0.0% 0.02%
EBITDA 3Y 1.3% 67.3% 35.0% 21.6% 12.5% 4.9% 0.2% 0.3% -9.6% -10.2% -9.6% -7.0% -1.0% 2.0% 7.4% 9.4% 14.7% 20.2% 27.0% 29.4% 29.36%
EBITDA 5Y — — — — — — — — 53.3% 29.0% 16.5% 11.6% 10.5% 10.2% 11.6% 12.3% 5.1% 4.5% 4.6% 6.0% 5.99%
Gross Profit 3Y 79.6% 39.7% 22.0% 14.5% 13.1% 11.4% 10.3% 9.2% 4.8% 6.9% 8.9% 11.3% 15.0% 15.8% 17.0% 17.4% 18.6% 19.5% 15.8% 18.4% 18.40%
Gross Profit 5Y — — — — — — — — 44.9% 26.1% 18.0% 15.0% 16.0% 15.8% 15.7% 15.4% 12.9% 12.9% 10.4% 11.9% 11.90%
Op. Income 3Y 78.5% 37.2% 18.5% 15.2% 13.0% 10.4% 9.1% 7.8% 1.5% 3.7% 5.4% 8.0% 13.0% 14.1% 16.3% 17.0% 18.8% 11.6% 2.9% 1.0% 0.96%
Op. Income 5Y — — — — — — — — 42.5% 23.5% 15.1% 14.6% 15.5% 15.0% 15.2% 15.2% 11.5% 6.8% 1.1% -0.2% -0.19%
FCF 3Y -11.0% -6.6% -4.2% -11.0% 24.7% 16.6% 14.3% 19.8% 25.3% 31.9% 36.3% 20.0% 9.3% -0.7% -9.9% -6.4% -2.2% 12.1% 15.6% 11.8% 11.78%
FCF 5Y — — — — — — — — -5.1% -4.7% -4.6% -6.4% 17.8% 13.8% 12.2% 12.8% 13.5% 22.2% 21.7% 12.8% 12.84%
OCF 3Y 1.1% 77.9% 54.8% 35.3% 28.9% 18.8% 10.4% 5.0% -0.6% 1.6% 5.1% 2.7% 0.9% -1.9% -4.7% -0.1% 4.5% 25.9% 36.1% 40.5% 40.53%
OCF 5Y — — — — — — — — 44.6% 28.2% 17.5% 12.6% 13.4% 12.9% 13.0% 14.1% 15.1% 24.0% 25.1% 19.6% 19.56%
Assets 3Y 13.8% 18.4% 18.4% 18.8% 18.8% 16.8% 16.8% 17.9% 17.9% 24.6% 24.6% 22.3% 22.3% 18.7% 18.7% 15.5% 15.5% 15.8% 15.8% 12.8% 12.77%
Assets 5Y — — — — — — — — 15.9% 22.6% 22.6% 19.5% 19.5% 18.1% 18.1% 17.5% 17.5% 15.8% 15.8% 15.3% 15.31%
Equity 3Y 20.5% 25.1% 25.1% 20.7% 20.7% 19.4% 19.4% 17.2% 17.2% 12.0% 12.0% 10.4% 10.4% 8.4% 8.4% 8.2% 8.2% 8.7% 8.7% 11.3% 11.34%
Book Value 3Y 20.3% 25.0% 24.9% 20.5% 20.6% 19.1% 19.2% 18.5% 17.2% 12.0% 11.7% 10.5% 10.4% 8.4% 8.4% 8.1% 8.1% 8.7% 8.7% 11.3% 11.30%
Dividend 3Y 5.3% -4.4% -6.0% -4.7% -3.2% -10.8% -20.7% -36.3% — — — -20.6% — — — 71.0% 44.2% 45.1% 36.4% 22.4% 22.44%
Growth Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue Stability 0.85 0.89 0.91 0.98 0.91 0.93 0.92 0.97 0.83 0.89 0.94 0.96 0.91 0.91 0.93 0.94 0.88 0.91 0.93 0.95 0.953
Earnings Stability 0.93 0.88 0.76 0.61 0.58 0.35 0.13 0.03 0.20 0.08 0.02 0.00 0.09 0.13 0.11 0.11 0.37 0.24 0.10 0.00 0.004
Margin Stability 0.96 0.95 0.96 0.97 0.98 0.97 0.98 0.96 0.96 0.95 0.96 0.97 0.98 0.98 0.97 0.97 0.97 0.97 0.97 0.96 0.963
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.97 0.99 0.94 0.91 0.89 0.85 0.83 0.81 0.87 0.92 0.97 0.94 0.93 0.86 0.88 0.86 0.86 0.90 0.90 0.50 0.500
Earnings Smoothness 0.92 0.99 0.85 0.75 0.67 0.54 0.46 0.39 0.62 0.78 0.93 0.85 0.84 0.71 0.74 0.70 0.70 0.77 0.78 0.57 0.571
ROE Trend 0.00 -0.01 -0.04 -0.04 -0.10 -0.10 -0.12 -0.12 -0.09 -0.07 -0.04 -0.03 -0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.05 0.045
Gross Margin Trend -0.00 -0.01 -0.00 -0.01 -0.02 -0.02 -0.03 -0.04 -0.02 -0.00 0.00 0.02 0.03 0.03 0.03 0.04 0.04 0.03 -0.04 -0.00 -0.002
FCF Margin Trend 0.03 0.05 0.07 0.04 0.02 0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.02 -0.03 -0.00 -0.00 -0.00 -0.000
Sustainable Growth Rate 21.3% 18.2% 16.9% 15.4% 12.1% 9.7% 8.6% 7.9% 8.7% 8.3% 9.5% 8.8% 9.1% 9.7% 10.6% 10.2% 10.6% 10.1% 11.1% 13.6% 13.65%
Internal Growth Rate 18.6% 16.0% 14.7% 12.9% 9.9% 7.9% 6.9% 5.8% 6.4% 5.4% 6.2% 5.7% 5.9% 5.8% 6.3% 6.3% 6.5% 6.4% 7.1% 9.3% 9.28%
Cash Flow Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
OCF/Net Income 0.83 0.98 1.19 1.17 1.35 1.35 1.31 1.30 1.10 1.20 1.16 1.38 1.48 1.37 1.30 1.39 1.43 1.99 1.91 1.49 1.492
FCF/OCF 0.60 0.64 0.67 0.62 0.57 0.60 0.65 0.80 1.00 1.00 1.00 0.86 0.76 0.66 0.56 0.51 0.47 0.42 0.40 0.41 0.405
FCF/Net Income snapshot only 0.605
OCF/EBITDA snapshot only 0.842
CapEx/Revenue 6.1% 6.2% 6.4% 6.7% 7.2% 5.6% 4.0% 1.9% 0.0% 0.0% 0.0% 1.3% 2.5% 3.6% 4.7% 5.6% 6.5% 10.2% 11.0% 10.5% 10.50%
CapEx/Depreciation snapshot only 2.469
Accruals Ratio 0.03 0.00 -0.03 -0.02 -0.04 -0.03 -0.02 -0.02 -0.01 -0.01 -0.01 -0.02 -0.03 -0.02 -0.02 -0.03 -0.03 -0.07 -0.07 -0.05 -0.047
Sloan Accruals snapshot only 0.006
Cash Flow Adequacy snapshot only 1.507
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Dividend Yield 0.4% 0.4% 0.4% 0.4% 0.5% 0.3% 0.2% 0.1% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.2% 0.2% 0.3% 0.4% 0.3% 0.30%
Dividend/Share $4.40 $4.20 $4.00 $4.00 $4.00 $3.00 $2.00 $1.00 $0.00 $0.00 $0.00 $0.50 $1.00 $1.50 $2.00 $2.50 $3.00 $4.58 $5.08 $4.60 $6.00
Payout Ratio 11.2% 10.8% 11.1% 11.5% 14.1% 12.4% 9.7% 5.4% 0.0% 0.0% 0.0% 2.3% 4.4% 5.8% 7.0% 8.6% 9.8% 14.0% 14.2% 10.2% 10.21%
FCF Payout Ratio 22.6% 17.4% 13.9% 15.8% 18.4% 15.3% 11.3% 5.1% 0.0% 0.0% 0.0% 1.9% 3.9% 6.4% 9.5% 12.1% 14.7% 16.6% 18.6% 16.9% 16.90%
Total Payout Ratio 11.2% 10.8% 11.1% 11.5% 14.1% 12.4% 9.7% 5.4% 0.0% 0.0% 0.0% 2.3% 4.4% 5.8% 7.0% 8.6% 9.8% 14.0% 14.2% 10.2% 10.21%
Div. Increase Streak 1 0 0 0 0 0 0 0 — — — 0 0 0 0 0 1 1 1 1 0
Chowder Number 0.18 -0.12 -0.16 -0.13 -0.09 -0.28 -0.50 -0.75 — — — -0.50 — — — 4.00 2.00 2.06 1.54 0.84 0.841
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.1% -0.1% -0.1% -0.1% -0.1% -0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.3% 0.3% 0.2% 0.3% 0.4% 0.3% 0.2% 0.1% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.2% 0.2% 0.3% 0.4% 0.3% 0.29%
DuPont Factors
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Tax Burden (NI/EBT) 0.82 0.81 0.80 0.79 0.75 0.71 0.68 0.64 0.64 0.64 0.64 0.65 0.66 0.66 0.68 0.65 0.67 0.69 0.70 0.73 0.728
Interest Burden (EBT/EBIT) 1.07 1.07 1.07 1.05 1.06 1.08 1.10 1.04 1.04 0.99 1.04 0.90 0.89 0.91 0.88 0.87 0.88 0.87 0.87 0.97 0.972
EBIT Margin 0.21 0.20 0.19 0.18 0.15 0.13 0.12 0.11 0.12 0.11 0.12 0.12 0.12 0.13 0.14 0.15 0.14 0.15 0.16 0.17 0.167
Asset Turnover 0.96 0.89 0.89 0.85 0.85 0.80 0.82 0.77 0.77 0.69 0.75 0.78 0.83 0.75 0.77 0.78 0.80 0.79 0.80 0.80 0.800
Equity Multiplier 1.36 1.32 1.32 1.34 1.34 1.33 1.33 1.43 1.43 1.62 1.62 1.62 1.62 1.78 1.78 1.72 1.72 1.68 1.68 1.61 1.607
Per Share
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
EPS (Diluted TTM) $39.45 $38.78 $36.06 $34.83 $28.40 $24.20 $20.69 $18.60 $19.36 $19.41 $22.24 $21.59 $22.74 $26.08 $28.75 $29.04 $30.68 $32.79 $35.86 $44.99 $44.99
Book Value/Share $185.36 $207.52 $207.39 $216.33 $216.51 $227.67 $227.71 $230.57 $230.35 $242.46 $242.35 $249.72 $249.68 $264.24 $264.08 $273.55 $273.81 $292.80 $292.74 $317.89 $375.40
Tangible Book/Share $179.02 $198.53 $198.41 $208.22 $208.39 $218.72 $218.77 $222.78 $222.57 $232.73 $232.64 $240.52 $240.48 $255.13 $254.97 $265.55 $265.81 $284.80 $284.74 $310.10 $310.10
Revenue/Share $214.95 $222.17 $222.84 $229.67 $230.65 $232.75 $237.35 $246.59 $246.44 $263.52 $283.39 $303.98 $323.85 $336.56 $343.95 $352.01 $360.86 $368.97 $374.69 $380.28 $399.11
FCF/Share $19.51 $24.15 $28.71 $25.24 $21.80 $19.63 $17.70 $19.50 $21.22 $23.32 $25.91 $25.70 $25.49 $23.62 $21.02 $20.66 $20.35 $27.66 $27.32 $27.20 $12.56
OCF/Share $32.67 $37.85 $42.95 $40.64 $38.36 $32.63 $27.14 $24.22 $21.22 $23.32 $25.91 $29.75 $33.59 $35.79 $37.23 $40.44 $43.74 $65.20 $68.44 $67.14 $30.75
Cash/Share $29.87 $38.20 $38.18 $53.52 $53.56 $51.09 $51.10 $86.00 $85.92 $36.83 $36.82 $33.34 $33.33 $35.62 $35.60 $43.61 $43.65 $50.58 $50.57 $47.23 $47.22
EBITDA/Share $52.63 $52.84 $50.24 $49.86 $44.09 $39.91 $36.21 $36.89 $38.33 $40.35 $43.85 $47.95 $51.02 $56.16 $62.24 $65.18 $66.49 $69.43 $74.26 $79.76 $79.76
Debt/Share $10.46 $12.09 $12.09 $31.80 $31.82 $28.91 $28.92 $58.46 $58.41 $78.37 $78.34 $56.72 $56.71 $47.41 $47.38 $53.65 $53.70 $50.42 $50.41 $31.88 $31.88
Net Debt/Share $-19.41 $-26.11 $-26.09 $-21.72 $-21.74 $-22.18 $-22.18 $-27.54 $-27.51 $41.54 $41.52 $23.39 $23.38 $11.79 $11.78 $10.04 $10.05 $-0.16 $-0.16 $-15.35 $-15.35
Academic Models
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 10.167
Altman Z-Prime snapshot only 18.017
Piotroski F-Score 5 5 6 5 4 4 5 5 6 5 5 7 7 9 8 8 8 8 8 9 9
Beneish M-Score -2.38 -2.16 -2.35 -2.33 -2.42 -2.48 -2.44 -2.37 -2.44 -1.99 -1.99 -2.05 -2.03 -2.57 -2.58 -2.39 -2.40 -2.47 -2.40 -2.68 -2.684
Ohlson O-Score snapshot only -12.196
ROIC (Greenblatt) snapshot only 17.40%
Net-Net WC snapshot only $139.06
EVA snapshot only $9929099496.14
Credit
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Credit Rating snapshot only AA+
Credit Score 95.76 95.61 95.53 95.45 95.83 95.64 96.20 92.30 89.17 83.78 84.90 82.75 85.33 89.95 90.34 93.08 93.15 93.33 93.38 94.68 94.677
Credit Grade snapshot only 2
Credit Trend snapshot only 1.600
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 85
Sector Credit Rank snapshot only 91

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms